"At HonorHealth, our team members and physicians are focused on doing what’s right for our community. That is why we look more closely, go beyond the surface and see every dimension in everything we do, providing a level of care that defies the expected. And, we promise to not only live up to our name, but also follow through with action: Delivering care with integrity, respect and dedication to you."

During the past decade, HonorHealth Scottsdale Osborn Medical Center conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 3 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "HonorHealth Scottsdale Osborn Medical Center" #1 sponsor was "Nader Sanai" with 2 trials, followed by "Boston Scientific Corporation" with 1 trials sponsored, "HonorHealth Research Institute" with 1 trials sponsored, "Ipsen" with 1 trials sponsored and "Kinevant Sciences GmbH" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "HonorHealth Scottsdale Osborn Medical Center" #1 collaborator was "Barrow Neurological Institute" with 3 trials as a collaborator, "Ivy Brain Tumor Center" with 3 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 1 trials as a collaborator and "Neolight" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "HonorHealth Scottsdale Osborn Medical Center" are "GBM" (2 trials), "Glioblastoma" (2 trials), "Glioma" (2 trials), "Anesthesia" (1 trials) and "COVID-19" (1 trials). Many other conditions were trialed in "HonorHealth Scottsdale Osborn Medical Center" in a lesser frequency.

Most popular intervention types in "HonorHealth Scottsdale Osborn Medical Center" are "Device" (4 trials), "Drug" (4 trials), "Biological" (2 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "ACUITY X4 quadripolar coronary venous lead and RELIANCE 4-FRONT defibrillation lead" (1 trials), "Abemaciclib" (1 trials), "AboBoNT-A" (1 trials) and "Calypso® 4D Localization System" (1 trials). Other intervention names were less common.

The vast majority of trials in "HonorHealth Scottsdale Osborn Medical Center" are 10 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "HonorHealth Scottsdale Osborn Medical Center". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in HonorHealth Scottsdale Osborn Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in HonorHealth Scottsdale Osborn Medical Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".